For me it was so exciting to hear her voice . I am so used to her being at so many breast cancer events and I missed her. I was also pleased that when I asked her “Although I am very excited about the deadline to end breast cancer in 2020, what is being done to help the metastatic community now?” She expressed that it was an important question and went in to some details about advances being made in the metastatic setting especially in relation to molecular profiling and understanding why it occurs. There is still so much work to do especially when it comes to metastatic breast cancer.
First of all I want to announce, fanfare please, that I am back to work at the Foundation! I am feeling stronger every day with my new bone marrow and very short hair. If I were to encapsulate in one word what my recent experience with leukemia has inspired, I would have to say impatience. I have talked for years about the collateral damage that patients experience from cancer treatments and now I know them first hand. They are not acceptable!
While we all want a cure, we have to focus collectively on finding the cause! I have come back to work with new energy focused on research strategies going forward that can have an immediate impact on women’s lives and move
While out on leave, my team at the Foundation has been steadfast in their efforts to introduce our innovative research projects. We launched our Bacterial and Viral Diversity Study in collaboration with Delphine Lee MD at the John Wayne Cancer Institute this November. This is a very exciting exploratory study to see if a virus or bacteria could cause breast cancer. We have already begun out sample collections at the Foundation. We are collecting fluid from the ducts of Army of Women volunteers and